OSE Immunotherapeutics met a jour l’information sur les procedures en cours
OSE Immunotherapeutics met a jour l'information sur les procedures en cours GlobeNewswire July 02, 2025 OSE Immunotherapeutics provides an update on ongoing proceedings NANTES, France, July 2, 2025, 8 AM – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) announces that following the hearing on June 24th, 2025, the President of the Nantes Commercial Court rejected, […]